“We continue to be encouraged by the early clinical results demonstrated by the Parachute® implant. In all of our previous studies we have seen similar improvements in treated heart failure patients.”Thomas Engels, Vice President of Clinical Affairs of CardioKinetix Inc.
The Parachute® implant is a percutaneous ventricular restoration (PVR) therapy. After a heart attack, many heart failure patients experience enlargement of their left ventricle causing a decrease in cardiac output resulting in heart failure symptoms such as shortness of breath. The Parachute® implant partitions the damaged muscle, isolating the non-functional muscle segment from the functional segment, which decreases the overall volume and restores a more normal geometry and function in the left ventricle.
The procedure, which takes approximately 75 minutes, is performed in a catheterization laboratory setting and patients are under conscious sedation. Prior to implantation, the site performs an echocardiogram and cardiac CT to understand which size of the Parachute is needed.